-
Mashup Score: 6Primary Cancer Predictor - 9 hour(s) ago
Web site created using create-react-app
Categories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3
The AAMC Visiting Student Learning Opportunities™ program is designed for medical and public health students to pursue short-term learning opportunities.
Source: students-residents.aamc.orgCategories: General Medicine News, Hem/OncsTweet-
Students interested in #radonc should rotate in our department @RadOncUH. Our 30+ prior rotating students from across the USA 🇺🇸 and abroad give it a 5 star review⭐️⭐️⭐️⭐️⭐️ #radonc Applications: https://t.co/IMiRJQ73wC https://t.co/6LbCOc08mV
-
-
Mashup Score: 44
Why consider radiation oncology as your career?
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
Considering a career in radiation oncology: a guide for medical students Lecture that @ShaunaRadOnc and I give to junior medical students at @CWRUSOM @CleClinicLCM, now on @YouTube @RadOncUH @UHhospitals @ClevelandClinic @ARRO_org @ASTRO_org #radonc https://t.co/519zumTo5C
-
-
Mashup Score: 11Zaorsky educational threads - 4 month(s) ago
Key: 🧵 thread / visiting professor talk / lecture | 📖 peer-reviewed manuscript / publication | 📄 1 page summary / list | 🖼️ illustration / figure | 📚 book | 📺 video | 🧮 biostatistics, math |💲 finance, billing, etc | 🇺🇸 USA-specific |🌍 International |🔗 link to other site | ✍️ writing a…
Source: docs.google.comCategories: General Medicine News, Hem/OncsTweet-
This is part of a larger series, found at https://t.co/9pL2tKBoer Including: How to write a research manuscript Checklist before manuscript submission How to make figures for a research manuscript How to write an abstract for presentation at a meeting How to do a meta-analysis
-
-
Mashup Score: 6Interim Futility Results of NRG-HN005, A Randomized, Phase II/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients - 4 month(s) ago
NRG-HN005 was a phase II/III randomized study comparing each of two experimental arm(s) against a control arm from RTOG 1016, in patients with p16+, non-smoking associated, locoregionally advanced oropharyngeal cancer. The phase II primary endpoint was non-inferiority (NI) of progression-free survival (PFS). The phase III trial would have included the experimental arm(s) found to be NI in phase II, with co-primary endpoints of NI PFS and superior quality of life.
Source: www.redjournal.orgCategories: General Medicine News, Hem/OncsTweet-
@DrLesterColl NRG HN 005 presented at #ASTRO24: no benefit of RT + nivolumab over RT + chemo for p16+ oropharyngeal cancer https://t.co/wDedd0Jl3k Thanks @CJTsaiMDPhD https://t.co/CNAcjnICxG https://t.co/uGyw8EDaph
-
-
Mashup Score: 4Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005 - 4 month(s) ago
Concurrent chemoradiation (cCRT) followed by prophylactic cranial irradiation (PCI) has been the standard of care for LS-SCLC for decades. NRG-LU005 (NCT03811002) tested the addition of atezo to cCRT in this open label, randomized phase III international trial. Here, results of the 2nd planned interim analysis are reported as recommended by the Data Monitoring Committee.
Source: www.redjournal.orgCategories: General Medicine News, Hem/OncsTweet-
NRG LU 005 presented at #ASTRO24: Chemoradiation with concurrent and consolidation atezolizumab did not improve survival in LS-SCLC https://t.co/ySRuOCoVNc Thanks @DrLesterColl https://t.co/KIPxGWzKRA https://t.co/eaTIbil9rc
-
-
Mashup Score: 60Media Awards - American College of Radiation Oncology - 4 month(s) ago
The American College of Radiation Oncology annually recognizes excellence in reporting on radiation oncology published by journalists in the United States. The ACRO Excellence in Radiation Oncology Media Awards was launched by the College in 2023 to recognize outstanding and accurate reporting of radiation oncology news in the United States. Winners of the 2024 awards program will be recognized at the ACRO Annual Meeting in March 2025 in Las Vegas, NV. Please read the following guidelines before making a
Source: acro.orgCategories: General Medicine News, Hem/OncsTweet-
The @ACRORadOnc media awards for excellence in radiation oncology reporting are open. I think #RadOnc owes @QuadShotNews a nomination. Thanks @SamuelMarcromMD @LauraDoverMD et al for updating the community with critical studies. https://t.co/NK5DKDXQkh @ASTRO_org @ARRO_org
-
-
Mashup Score: 4
We observed that people living with cancer are at 2 times greater risk of dying from COVID-19 compared with the general US population. This work may be used by physicians and public health officials in the creation of survivorship programs that mitigate the risk of COVID-19 mortality.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet-
Death from COVID-19 among patients with cancer https://t.co/66ZFLVa2EM Via: @JNCI_Now @KyleMani_ @mwang_cwru @DrSpratticus https://t.co/s6feOte9tM
-
-
Mashup Score: 0
This is “AHNS Virtual Education Series – Big Data in Academic Medical Research” by American Head and Neck Society on Vimeo, the home for high quality videos…
Source: vimeo.comCategories: General Medicine News, Hem/OncsTweet-
Recording now posted: https://t.co/pELRLh0VQQ
-
-
Mashup Score: 1Academic Publishing - 6 month(s) ago
It’s not about the money…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
Academic publishing from @DGlaucomflecken https://t.co/4w3RQgV4Fz https://t.co/cZ9UFq0yte https://t.co/0T2Ymm8bTk https://t.co/QBc4HaczjD
-
Beta version of our app to predict the site of primary cancer in the setting of metastatic cancer (e.g., based on imaging without biopsy): https://t.co/gzMAL2gUkp The accuracy is ~85%. Full manuscript coming soon. https://t.co/hdu0KkHSJc